title: [Prevention and control of nosocomial and health-care facilities associated infections caused by species of Candida and other yeasts].
abstract: Knowledge of the epidemiology of invasive fungal diseases caused by yeasts (Candida spp., especially) in health care settings allows the establishment of the levels necessary for its prevention. A first step is to identify groups of patients at high risk of nosocomial invasive fungal infections, establish accurate risk factors, observing the periods of greatest risk, and analyze the epidemiological profile in genera and species as well as the patterns of antifungal resistance. Secondly, mechanisms to avoid persistent exposure to potential fungal pathogens must be programed, protecting areas and recommending measures such as the control of the quality of the air and water, inside and outside the hospital, and other products or substances able to cause outbreaks. Finally, apart from the correct implementation of these measures, in selected patients at very high risk, the use of antifungal prophylaxis should be considered following the guidelines published.
authors.affiliation: Miguel Salavert Lletí. Unidad de Enfermedades Infecciosas; Hospital Universitario y Politécnico La Fe, Boulevar sur s/n; 46026; Valencia, Spain. salavert_mig@gva.es.
authors.forename: Javier
authors.initials: J
authors.lastname: Pemán
authors.forename: Rafael
authors.initials: R
authors.lastname: Zaragoza
authors.forename: Miguel
authors.initials: M
authors.lastname: Salavert
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D006761:Hospitals; D006801:Humans; D009181:Mycoses / Q000382:microbiology / Q000517:prevention & control*; D015003:Yeasts
chemical_list: D000935:Antifungal Agents